4.1.4 Compliance and adherence

Compliance and Adherence – Relevance and Methods of Maximisation

Compliance and adherence are terms used to describe the extent to which a patient follows the recommended treatment regimen.

Compliance:

Compliance refers to the extent to which a patient follows the recommended treatment regimen for a medical condition. In other words, it refers to how well a patient adheres to a prescribed course of treatment, such as taking medications as directed, following lifestyle changes, or attending appointments. Compliance is a critical factor in the effective management of many medical conditions, including psychiatric disorders.

There are several factors that can influence compliance, including the nature of the condition, the patient’s beliefs and attitudes towards the treatment, the complexity of the regimen, the presence of side effects, and the patient’s relationship with their healthcare provider.

Poor compliance can lead to a number of adverse outcomes, including increased symptoms, disease exacerbation, increased healthcare utilization, and decreased quality of life. On the other hand, high levels of compliance can lead to better health outcomes and improved quality of life for the patient (Simon, 1999).

Adherence:

Adherence refers to the extent to which a patient follows the recommended treatment regimen for a medical condition, including taking medications as prescribed, following lifestyle changes, or attending appointments. Adherence is often used interchangeably with the term “compliance,” though some experts distinguish between the two terms by defining adherence as a patient’s voluntary and active decision to follow the prescribed treatment, while compliance refers to the extent to which they actually do so.

Adherence is critical for the effective management of many medical conditions, including psychiatric disorders, as it is essential for ensuring that patients receive the full therapeutic benefits of their medication. Poor adherence can result in a number of adverse outcomes, such as increased symptoms, disease exacerbation, increased healthcare utilization, and decreased quality of life (Haynes, 2002).

There are several factors that can influence adherence, including the nature of the condition, the patient’s beliefs and attitudes towards the treatment, the complexity of the regimen, the presence of side effects, and the patient’s relationship with their healthcare provider.

Relevance and methods of maximisation:

Methods of Maximization: To maximize compliance and adherence to psychotropic medication, the following strategies can be used:

  1. Patient Education: Providing patients with clear and comprehensive information about their condition, medications, and the importance of taking their medications as prescribed can help to increase compliance.
  2. Simplifying the Regimen: Simplifying the medication regimen, such as by reducing the number of doses or using once-daily dosing, can help to improve adherence.
  3. Medication Reminders: Providing patients with medication reminders, such as pillboxes, text message reminders, or phone calls, can help to increase compliance.
  4. Collaborative Decision-Making: Involving patients in the decision-making process about their medications and treatment plan can help to increase their buy-in and improve adherence.
  5. Addressing Side Effects: Addressing side effects and working with patients to find the most tolerable medication regimen can help to improve adherence.
  6. Monitoring Adherence: Regular monitoring of medication adherence, such as through pill counts or electronic monitoring systems, can help to identify and address issues related to non-compliance.
  7. Collaborating with other Healthcare Providers: Collaborating with other healthcare providers, such as primary care physicians and pharmacists, can help to ensure that patients receive consistent and comprehensive care that supports adherence to their medication regimen.

References:

(1) Haynes, R. B., McDonald, H. P., Garg, A. X., & Montague, P. (2002). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews, (1).

(2) Simon, G. E., Katon, W., Russo, J., Mauk, J., Robinson, P., & Ludman, E. (1999). Compliance with antidepressant treatment. The Journal of the American Medical Association, 282(20), 1912-1918.